Overweight and obese children with asthma may mistake symptoms such as exertional dyspnea and esophageal reflux for loss of asthma control, leading to unnecessary use of rescue medications, according to a study published online Oct. 14 in the Journal of Allergy and Clinical Immunology
Study results show that treatment with a proton pump inhibitor does not reduce the effectiveness of metformin treatment in patients with type 2 diabetes.
This 28-year-old woman presented with a large hyperpigmented patch on the right side of her upper back. Although the lesion developed over the past 2 years, it has been “sinking in” over the past 2 weeks. The patient denies any trauma, pain, discomfort, or pruritis, as well as any family history of cancers, lymphoma, or autoimmune disease. However, she has a history of gastroesophageal reflux disease and onychomycosis, and her grandfather has a similar lesion.
For patients with gastroesophageal reflux disease, those who receive a proton pump inhibitor prescription from gastroenterologists are more likely to be optimal users and have better symptom control, according to a study published in the June issue of the American Journal of Gastroenterology.
With no standards in place to guide referrals for children with gastroesophageal reflux disease, variation in procedural decision-making among pediatric subspecialists is expected.
A minimally-invasive, surgically-implanted esophagus band developed at Stony Brook University Hospital effectively reduces symptoms of gastroesophageal reflux disease (GERD).